🟡

Class II

May cause reversible problems

💊Medicamento#D-0806-2026

MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.

What happened?

CGMP Deviations

What should I do now?

  1. 1Check the lot number on your product packaging.
  2. 2If you have it, stop using it.
  3. 3Return it to your pharmacy or store for a refund.
  4. 4If you already used it and feel unwell, see your doctor immediately.
  5. 5Report adverse effects to the FDA: 1-800-FDA-1088.
Company
Baxter Healthcare Corporation
Status
Ongoing
Report date
2026-09-09
Initiated
2026-08-06
Distribution
US Nationwide; Puerto Rico; and Chile.
Quantity
N/A

This is NOT medical advice. Consult with your pharmacist or doctor before making decisions.